A Brazilian physical therapist has been leading a unique project in Rio de Janeiro since 2018, trying to help patients with ...

A Brazilian physical therapist has been leading a unique project in Rio de Janeiro since 2018, trying to help patients with ...

Corcept Therapeutics CORT announced that it has submitted a new drug application (NDA) to the FDA seeking approval for its lead pipeline candidate, relacorilant, for treating a new indication. The ...

The FDA already is scheduled to decide by Dec. 30 whether the same drug can be used by patients with hypercortisolism, also ...

As for those with hyperglycemia with or without hypertension at baseline, relacorilant significantly improved fasting glucose ...

The next generation of deep-brain stimulation automatically corrects the precise brain waves that create symptoms of ...

Italian pharma major Recordati presented four poster presentations and one product theater featuring the company’s endocrinology portfolio at the Endocrine Society’s annual meeting, ENDO 2025, taking ...

For many people, weight loss is often framed as a matter of willpower – a simple equation of exercising regularly and eating a healthy diet. But, Dr. Sindhura Bandaru, an ...

Corcept Therapeutics Incorporated (NASDAQ:CORT) is one of the best NASDAQ growth stocks to buy for the next 3 years. On June ...

Hospitals nationwide are grappling with high patient volumes, staffing shortages and inefficient capacity management — all while being asked to deliver timely, high-quality care. During a recent ...

Agents that directly lower ACTH secretion by a pituitary adenoma represent an attractive option for the treatment of Cushing's disease, as these drugs directly target the pathogenesis of disease ...

Background: Cushing’s disease is a rare condition associated with a high cardiovascular risk and hypercortisolemia-related hemodynamic dysfunction, the extent of which can be assessed with a ...